Koltsov, Jayme C. B. http://orcid.org/0000-0001-8145-3308
Smuck, Matthew W.
Alamin, Todd F.
Wood, Kirkham B.
Cheng, Ivan
Hu, Serena S.
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR001085)
Article History
Received: 9 March 2020
Revised: 12 June 2020
Accepted: 4 August 2020
First Online: 13 August 2020
Compliance with ethical standards
:
: The datasets analyzed during the current study are not publicly available, as access to the IBM® MarketScan® databases requires a data use agreement and the data are not freely available.
: The authors have the following unrelated disclosures: JK: co-investigator on grants from the National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases), North American Spine Society, and Orthopaedic Research and Education Foundation; MS: stock ownership in Bluejay Mobile Health and NuSpine, private investments in Vivametrica, consulting for State Farm and Spine Biopharma, travel funds from Spine Intervention Society, board of directors for Spine Intervention Society, scientific advisory board for Bluejay Mobile Health and NuSpine, principal investigator on grants from Relievant Medsystems and Rewalk; TA: private investments in Empirical Spine and Disc Diagnostics, consulting for Medtronic, Depuy, and Empirical Spine, speaking arrangement for Globus, board of directors for Empirical Spine, fellowship support from Omega; KW: royalties from Globus Spine, scientific advisory board for LifeSpine and Kuyucera; IC: royalties from Nuvasive, SpineWave, and SpineCraft, stock ownership in Nuvasive, private investments in Cytonics, Spine Innovations, and SpinalCyte, consulting for Stryker Spine and Nuvasive, scientific advisory board for Notogen, and research support from Limiflex; SH: Royalties and stock ownership in Nuvasive, principal investigator on a grant from the North American Spine Society.